We have exciting news to share! ACTION has joined forces with OmniLife! Please see the OmniLife press release below or check out the full Business Wire press release here.
LEXINGTON, Ky —(BUSINESS WIRE) OmniLife, a health technology communication and collaboration platform, has finalized its formal collaboration with the Advanced Cardiac Therapies Improving Outcomes Network, or ACTION. The organizations will work together to drive innovation around patient care and clinical decision making, specifically with the goal of improving outcomes for children with heart failure.
ACTION works to improve critical outcomes for all pediatric and congenital heart failure patients through its learning network approach, which allows the organization to make critical improvements faster across a collaborative system of providers, patients, families, researchers, and industry. As of October 2021, ACTION includes 55 pediatric hospitals in North America and seven additional sites globally.
ACTION will leverage OmniLife’s technology platform and provider network to create a collective intelligence system for secure and real-time clinical decision support and sharing of best practices across their national network.
“It is wonderful to work with companies that are aligned with our mission of improving care and outcomes for children with heart failure. Working with OmniLife will help us advance learning and accelerate innovative research,” commented Dr. Angie Lorts, co-executive director of ACTION and Director of Ventricular Assist Device at Cincinnati Children’s Hospital Medical Center.
“We are very excited to be working with ACTION to accelerate innovation with pediatric heart failure patients,” said Dalton Shaull, CEO of OmniLife. “I have a very personal connected purpose to the missions of OmniLife and ACTION, and we are thrilled that our work together will benefit children around the world.”
OmniLife has been leading efforts to improve communication, decision making, and secure information exchange between all stakeholders in the greater allotransplant ecosystem. Additionally, OmniLife is currently participating in a clinical trial funded by the National Institutes of Health (NIH) for a Small Business Innovation Research (SBIR) which includes notable centers such as UPMC Children’s Hospital of Pittsburgh, Loma Linda University Transplant Institute, and Stanford Health Care Transplant Program.
OmniLife is a certified Benefit Corporation focused on maximizing the gift of life for purposes of transplantation and research. OmniLife is the only end-to-end communication system that is built specifically to create a more connected and collaborative allotransplant ecosystem. To learn more visit their website or contact email@example.com. https://www.getomnilife.com/about-us/
To learn more about OmniLife: